Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Phase 1, Open-Label, Single Dose Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant.
Journal: Psychopharmacology bulletin
Published: September 23, 2017
A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant.
Journal: Psychopharmacology bulletin
Published: September 23, 2017
Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder.
Journal: Journal of medical economics
Published: June 13, 2017
Buprenorphine implants in medical treatment of opioid addiction.
Journal: Expert review of clinical pharmacology
Published: June 03, 2017
Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia.
Journal: Clinical pharmacology in drug development
Published: January 26, 2017
Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
Journal: The American journal of managed care
Published: November 04, 2014
Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short Form.
Journal: Journal of child and adolescent psychopharmacology
Published: October 07, 2014
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Journal: Journal of managed care pharmacy : JMCP
Published: December 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026